These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22095394)

  • 1. Recurrent uveitis due to sildenafil usage in a patient with Behçet's disease.
    Işık M; Kılıç L; Doğan I
    Rheumatol Int; 2013 Mar; 33(3):803. PubMed ID: 22095394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are phosphodiesterase type 5 inhibitors associated with vision-threatening adverse events? A critical analysis and review of the literature.
    Azzouni F; Abu samra K
    J Sex Med; 2011 Oct; 8(10):2894-903. PubMed ID: 21771280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of sildenafil in melanoma incidence and mortality.
    Robinson JK
    JAMA Intern Med; 2014 Jun; 174(6):970-1. PubMed ID: 24710720
    [No Abstract]   [Full Text] [Related]  

  • 4. Ups and downs of Viagra: revisiting ototoxicity in the mouse model.
    Au A; Stuyt JG; Chen D; Alagramam K
    PLoS One; 2013; 8(11):e79226. PubMed ID: 24244454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracerebral hemorrhage after sildenafil citrate use: an incidental association?
    Ayberk G; Ozveren MF; Yaman ME; Tosun H
    Urol J; 2014 May; 11(2):1524-6. PubMed ID: 24807778
    [No Abstract]   [Full Text] [Related]  

  • 6. Treating erectile dysfunction and central neurological diseases with oral phosphodiesterase type 5 inhibitors. Review of the literature.
    Lombardi G; Nelli F; Celso M; Mencarini M; Del Popolo G
    J Sex Med; 2012 Apr; 9(4):970-85. PubMed ID: 22304626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute inferior myocardial infarction in a young male patient associated with Behcet's disease and sildenafil.
    Cetin M; Ozturk U; Cakici M; Yildiz E
    BMJ Case Rep; 2014 Jan; 2014():. PubMed ID: 24448432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Out of the blue"-safety and efficacy of pulmonary hypertension treatment in childhood*.
    Kraemer U; Wildschuth E; Tibboel D
    Pediatr Crit Care Med; 2014 May; 15(4):377-8. PubMed ID: 24801422
    [No Abstract]   [Full Text] [Related]  

  • 9. Sildenafil use and increased risk of incident melanoma in US men: a prospective cohort study.
    Li WQ; Qureshi AA; Robinson KC; Han J
    JAMA Intern Med; 2014 Jun; 174(6):964-70. PubMed ID: 24710960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonpigmenting mucosal fixed drug eruption due to sildenafil citrate.
    Ghosh SK; Bandyopadhyay D
    J Sex Med; 2009 Dec; 6(12):3500-1. PubMed ID: 20092472
    [No Abstract]   [Full Text] [Related]  

  • 11. Postcoital vomiting after taking sildenafil?
    Lamb M; Brahm N; Fox MD
    J Fam Pract; 2013 Feb; 62(2):61-2. PubMed ID: 23405374
    [No Abstract]   [Full Text] [Related]  

  • 12. Mistaken diagnosis of optic neuritis and the possible role of phosphodiasterase-5 inhibitors (Sildenafil/Viagra).
    Cullen JF; Chung HW
    Med J Malaysia; 2010 Dec; 65(4):315-6. PubMed ID: 21901956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between acute coronary syndrome and sildenafil.
    Ekinozu I; Aslantas Y; Tibilli H; Turker Y; Ozhan H
    Am J Emerg Med; 2013 Sep; 31(9):1424.e1-3. PubMed ID: 23791459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selectivity of avanafil, a PDE5 inhibitor for the treatment of erectile dysfunction: implications for clinical safety and improved tolerability.
    Wang R; Burnett AL; Heller WH; Omori K; Kotera J; Kikkawa K; Yee S; Day WW; DiDonato K; Peterson CA
    J Sex Med; 2012 Aug; 9(8):2122-9. PubMed ID: 22759639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-arteritic anterior ischemic optic neuropathy associated with erectile dysfunction medications].
    Krashin-Bichler I; Dotan G
    Harefuah; 2013 Feb; 152(2):84-7, 123. PubMed ID: 23513498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to initial PDE-5 inhibitor treatment: randomized open-label study comparing tadalafil once a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction.
    Buvat J; Büttner H; Hatzimouratidis K; Vendeira PA; Moncada I; Boehmer M; Henneges C; Boess FG
    J Sex Med; 2013 Jun; 10(6):1592-602. PubMed ID: 23551622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sildenafil-induced pigmented purpuric dermatosis.
    Koçak AY; Akay BN; Heper AO
    Cutan Ocul Toxicol; 2013 Mar; 32(1):91-2. PubMed ID: 22780873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial priapism.
    Hoyerup P; Azawi NH
    BMJ Case Rep; 2013 Aug; 2013():. PubMed ID: 23933863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sildenafil and mild pulmonary arterial hypertension: unjustified risks, with no tangible benefit.
    Prescrire Int; 2010 Oct; 19(109):206. PubMed ID: 21180373
    [No Abstract]   [Full Text] [Related]  

  • 20. Phosphodiesterase type 5 inhibitor abuse: a critical review.
    Lowe G; Costabile R
    Curr Drug Abuse Rev; 2011 Jun; 4(2):87-94. PubMed ID: 21696344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.